Blog

In the global fight against breast cancer, the power of diagnostic tools can spell the difference between life and death. Survival rates for the disease are greatly improved when the cancer is detected early, while post-treatment detection is paramount to verify the effectiveness of the

Treatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates with poorer treatment outcomes Credit: VHIO Treatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates with poorer treatment outcomes Led by investigators

In a groundbreaking study published on 7 November 2023, in the journal Microsystems & Nanoengineering, Researchers from the Shanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences, and Shanghai Tech University, have developed an innovative microfluidic magnetic detection system (μFMS) for analyzing tumor-derived

Barcelona, 19 December 2023 – p38a protein, a key enzyme in the regulation of various cellular functions, plays a crucial role in some diseases, including cancer, chronic inflammation, and neurodegenerative conditions. Since the discovery of p38a, various pharmaceutical companies and numerous research groups have dedicated

MIAMI, FLORIDA (Dec. 18, 2023) – Shanta Dhar, Ph.D., assistant director of Technology and Innovation at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has been named a fellow of the National Academy of Inventors. Credit: Photo by Sylvester MIAMI,

(Memphis, Tenn.—December 18, 2023) Children with bilateral Wilms tumor have a tumor in each of their kidneys — a condition that strongly suggests an underlying genetic or epigenetic predisposition driving the disease. Scientists at St. Jude Children’s Research Hospital gathered a large cohort of bilateral

Researchers at the Centre for Genomic Regulation in Barcelona, Spain, and the Wellcome Sanger Institute near Cambridge, UK, have comprehensively identified the allosteric control sites found in the protein KRAS. These are highly sought after targets for drug development, representing secret vulnerabilities which can be

(Denver—December 18, 2023) – Adopting a lung nodule program (LNP) may increase the detection of early lung cancer for patients who are not eligible for lung cancer screening under existing age eligibility criteria, according to a study published in the Journal of Thoracic Oncology, an

AUSTIN/HOUSTON – TAMEST (Texas Academy of Medicine, Engineering, Science and Technology) has announced Nidhi Sahni, Ph.D., The University of Texas MD Anderson Cancer Center, as the recipient of the 2024 Mary Beth Maddox Award and Lectureship in cancer research. She was chosen for her role

Funding an unconventional approach to fighting cancer that emphasizes the integration of diverse scientific disciplines, the U.S. Department of Defense has awarded $3.2 million to establish the Convergent Science Cancer Consortium (CSCC), led by Dean’s Professor of Biological Sciences Peter Kuhn at the USC Dornsife